PRESS RELEASE published on 12/08/2024 at 23:01, 1 year 8 months ago EQS-Adhoc: CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC CompuGroup Medical SE & Co. KGaA in advanced discussions with CVC Capital Partners plc for potential investment agreement and public tender offer. Potential offer price of EUR 22.00 per share Public Tender Offer CompuGroup Medical Investment Agreement CVC Capital Partners EUR 22.00 Per Share
BRIEF published on 11/07/2024 at 07:40, 1 year 9 months ago CompuGroup Medical Innovates Amid Q3 Earnings Decline Innovation Revenues CompuGroup Medical E-health Q3 Earnings
BRIEF published on 11/07/2024 at 07:40, 1 year 9 months ago CompuGroup Medical innove malgré la baisse de ses résultats au troisième trimestre Innovation CompuGroup Medical Revenus E-santé Résultats Du Troisième Trimestre
PRESS RELEASE published on 11/07/2024 at 07:35, 1 year 9 months ago CGM drives innovation in the third quarter while recording earnings decline with almost stable revenues CompuGroup Medical records decline in earnings but drives innovation in the third quarter with almost stable revenues. Key focus on recurring revenues and new product launches Innovation CompuGroup Medical Product Launches Recurring Revenues Earnings Decline
BRIEF published on 07/31/2024 at 18:45, 2 years 1 month ago CompuGroup Medical Appoints Prof. Dr. Daniel Gotthardt as New CEO Healthcare Technology CEO Appointment CompuGroup Medical Daniel Gotthardt Michael Rauch
BRIEF published on 07/31/2024 at 18:45, 2 years 1 month ago CompuGroup Medical nomme le professeur Daniel Gotthardt au poste de nouveau PDG CompuGroup Medical Technologie De La Santé Nomination Du PDG Michael Rauch Daniel Gothardt
BRIEF published on 07/31/2024 at 18:41, 2 years 1 month ago CompuGroup Medical SE & Co. KGaA nomme le professeur Daniel Gotthardt au poste de nouveau PDG CompuGroup Medical Changements Au Conseil D'administration Nomination D'un Nouveau PDG Michael Rauch Daniel Gothardt
BRIEF published on 07/31/2024 at 18:41, 2 years 1 month ago CompuGroup Medical SE & Co. KGaA Appoints Prof. Dr. Daniel Gotthardt as New CEO Board Changes CompuGroup Medical New CEO Appointment Daniel Gotthardt Michael Rauch
PRESS RELEASE published on 07/31/2024 at 18:40, 2 years 1 month ago CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO effective September 1, 2024. Previous CEO Michael Rauch to leave in mutual agreement. Company founder praises Rauch's contributions and highlights Gotthardt's medical background and entrepreneurial skills CEO Appointment CompuGroup Medical Prof. Dr. Daniel Gotthardt Company Founder Medical Background
PRESS RELEASE published on 07/31/2024 at 18:36, 2 years 1 month ago EQS-Adhoc: CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO, terminating Michael Rauch's contract. Daniel Gotthardt to assume position on Sep 1, 2024 Termination CEO Appointment CompuGroup Medical Management Change Prof. Dr. Daniel Gotthardt
Published on 09/04/2026 at 14:30, 2 hours 11 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/04/2026 at 14:00, 2 hours 41 minutes ago Horizon Aircraft Appoints Tom Hearne to Board of Directors and Names Him Audit Committee Chair
Published on 09/04/2026 at 13:30, 3 hours 11 minutes ago Suntex Enterprises Launches Ambitious $1 Billion+ North American Real Estate Development Initiative
Published on 09/04/2026 at 13:00, 3 hours 41 minutes ago Storm Further Upsizes Private Placement to $3.2M
Published on 09/04/2026 at 08:02, 8 hours 39 minutes ago Southern Energy Corp. Announces Restricted Share Award Grant
Published on 09/04/2026 at 16:30, 10 minutes ago BLUETTI, BSW-Solar, Shelly Group and Flatpeak Bring Industry Voices Together at IFA 2026 to Shape the Future of Smarter Energy
Published on 09/04/2026 at 16:12, 28 minutes ago Genel Energy PLC: Response to Rule 2.8 announcement from DNO ASA
Published on 09/04/2026 at 16:05, 35 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle PLC
Published on 09/04/2026 at 16:04, 37 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 09/04/2026 at 16:00, 41 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 41 minutes ago Nombre total de droits de vote et actions composant le capital social au 31 juillet 2026
Published on 09/04/2026 at 16:00, 41 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
Published on 09/04/2026 at 16:00, 41 minutes ago Nombre total de droits de vote et actions composant le capital social au 31 août 2026
Published on 09/04/2026 at 08:45, 7 hours 56 minutes ago MISE A DISPOSITION DOCUMENTS AG DU 28/10/2026